Amber glass vials or nitrogen-sealed aluminum bags provide primary barriers against environmental degradation, while secondary packaging including desiccant packets absorbs residual moisture that could compromise peptide stability
This is because using unauthorised medications can be unsafe due to unknown quality, dosing and risks
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
How GLP-1 helps insulin sensitivity GLP-1 receptor agonists improve insulin sensitivity rapidly, often before any weight loss occurs
.png)
